{
    "organizations": [],
    "uuid": "e8aaf17f5f71c3a046714b5d4eff6da8210faafc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-autolus-therapeutics-files-for-us/brief-autolus-therapeutics-files-for-u-s-ipo-of-up-to-100-million-idUSFWN1SE11T",
    "ord_in_thread": 0,
    "title": "Autolus Therapeutics Files For U.S. IPO Of Up To $100 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - AUTOLUS THERAPEUTICS LTD -\n* AUTOLUS THERAPEUTICS LTD FILES FOR U.S. IPO OF UP TO $100 MILLION – SEC FILING\n* AUTOLUS THERAPEUTICS LTD SAYS INTEND TO APPLY TO LIST ADSS ON THE NASDAQ GLOBAL MARKET UNDER THE SYMBOL “AUTL”\n* AUTOLUS THERAPEUTICS LTD SAYS GOLDMAN SACHS & CO. LLC, JEFFERIES, WELLS FARGO SECURITIES AND WILLIAM BLAIR ARE UNDERWRITERS TO U.S. IPO Source text: ( bit.ly/2FRMXK5 )\nOur ",
    "published": "2018-05-08T04:54:00.000+03:00",
    "crawled": "2018-05-08T16:41:08.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "autolus",
        "therapeutic",
        "ltd",
        "autolus",
        "therapeutic",
        "ltd",
        "file",
        "ipo",
        "million",
        "sec",
        "filing",
        "autolus",
        "therapeutic",
        "ltd",
        "say",
        "intend",
        "apply",
        "list",
        "adss",
        "nasdaq",
        "global",
        "market",
        "symbol",
        "autl",
        "autolus",
        "therapeutic",
        "ltd",
        "say",
        "goldman",
        "sachs",
        "llc",
        "jefferies",
        "well",
        "fargo",
        "security",
        "william",
        "blair",
        "underwriter",
        "ipo",
        "source",
        "text"
    ]
}